An issue was discovered in Keyfactor PrimeKey EJBCA before 7.9.0, related to possible inconsistencies in DNS identifiers submitted in an ACME order and the corresponding CSR submitted during finalization. During the ACME enrollment process, an order is submitted containing an identifier for one or multiple dnsNames. These are validated properly in the ACME challenge. However, if the validation passes, a non-compliant client can include additional dnsNames the CSR sent to the finalize endpoint, resulting in EJBCA issuing a certificate including the identifiers that were not validated. This occurs even if the certificate profile is configured to not allow a DN override by the CSR.
Severity
CVSS 3.1
9.8 critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
EPSS
0.5%(unchanged from 0.5% a week ago; 0.5% 30 days ago) estimated probability of exploitation activity in the next 30 days; 46th percentile. Scored 2026-11-22. A forecast for this CVE across the internet, not for your own systems.
Show the promptExplain CVE-2022-34831 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2022-34831?via=ask-ai-copy and https://cve.bz/cve/CVE-2022-34831?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2022-34831 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.
Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.